Chromogranin A. Storage and release in hypertension.

Autor: Takiyyuddin, M A, Cervenka, J H, Hsiao, R J, Barbosa, J A, Parmer, R J, O'Connor, D T

Publikováno v: Hypertension (0194911X); Mar1990, Vol. 15 Issue 3, p237-246, 10p

Racial differences in renal kallikrein excretion: effect of the ovulatory cycle.

Autor: Kailasam MT; Departments of Medicine and Reproductive Medicine and Center for Molecular Genetics, University of California, and Department of Veterans Affairs Medical Center, San Diego, California, USA., Martinez JA, Cervenka JH, Yen SS, O'connor DT, Parmer RJ

Publikováno v: Kidney international [Kidney Int] 1998 Nov; Vol. 54 (5), pp. 1652-8.

Chromogranin A in human hypertension. Influence of heredity.

Autor: Takiyyuddin MA; Department of Medicine, University of California, San Diego, USA., Parmer RJ, Kailasam MT, Cervenka JH, Kennedy B, Ziegler MG, Lin MC, Li J, Grim CE, Wright FA, et. al.

Publikováno v: Hypertension (Dallas, Tex. : 1979) [Hypertension] 1995 Jul; Vol. 26 (1), pp. 213-20.

Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?

Autor: Wu RA; Department of Medicine, University of California, San Diego 92161., Kailasam MT, Cervenka JH, Parmer RJ, Kennedy BP, Ziegler MG, O'Connor DT

Publikováno v: Journal of hypertension [J Hypertens] 1994 Nov; Vol. 12 (11), pp. 1243-7.

Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release.

Autor: Takiyyuddin MA; Department of Medicine, University of California, San Diego 92161., Brown MR, Dinh TQ, Cervenka JH, Braun SD, Parmer RJ, Kennedy B, O'Connor DT

Publikováno v: Journal of autonomic pharmacology [J Auton Pharmacol] 1994 Jun; Vol. 14 (3), pp. 187-200.